LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 24.81 | 84.90 | 1877 | 1769 | 1.0608 | 1.0271 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 26.51 | 84.90 | 1848 | 1923 | 0.9609 | 0.9824 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 26.51 | 84.90 | 1951 | 1923 | 1.0145 | 1.0064 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 26.51 | 84.90 | 1886 | 1923 | 0.9807 | 0.9914 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 26.51 | 84.90 | 2007 | 1923 | 1.0436 | 1.0190 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 28.21 | 84.90 | 1946 | 2091 | 0.9304 | 0.9690 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 28.21 | 84.90 | 2047 | 2091 | 0.9787 | 0.9907 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 28.21 | 84.90 | 2058 | 2091 | 0.9840 | 0.9930 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 28.21 | 84.90 | 2121 | 2091 | 1.0141 | 1.0061 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 29.92 | 84.90 | 2113 | 2237 | 0.9443 | 0.9759 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 29.92 | 84.90 | 2192 | 2237 | 0.9796 | 0.9913 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 29.92 | 84.90 | 2210 | 2237 | 0.9876 | 0.9947 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 29.92 | 84.90 | 2271 | 2237 | 1.0149 | 1.0063 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 31.62 | 84.90 | 2280 | 2449 | 0.9307 | 0.9706 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 31.62 | 84.90 | 2355 | 2449 | 0.9613 | 0.9838 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 31.62 | 84.90 | 2460 | 2449 | 1.0042 | 1.0017 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 31.62 | 84.90 | 2524 | 2449 | 1.0303 | 1.0124 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 33.32 | 84.90 | 2505 | 2722 | 0.9201 | 0.9670 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 33.32 | 84.90 | 2599 | 2722 | 0.9547 | 0.9815 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 33.32 | 84.90 | 2693 | 2722 | 0.9892 | 0.9957 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 33.32 | 84.90 | 2751 | 2722 | 1.0105 | 1.0042 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 35.03 | 84.90 | 2773 | 2991 | 0.9270 | 0.9707 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 35.03 | 84.90 | 2842 | 2991 | 0.9501 | 0.9802 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 35.03 | 84.90 | 2951 | 2991 | 0.9865 | 0.9947 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 35.03 | 84.90 | 3011 | 2991 | 1.0066 | 1.0026 | MN20160318_Q02 | F06 |